Literature DB >> 9316673

Postural tremor of Parkinson's disease.

J M Henderson1, C Yiannikas, J G Morris, R Einstein, D Jackson, K Byth.   

Abstract

Previous studies have reported the resting tremor (RT) of Parkinson's disease to occur at frequencies between 3-7 Hz and to be characterised by an alternating pattern of electromyographic (EMG) bursting activity between opposing muscles. A postural tremor (PT), of higher frequency (> 6 Hz) and with a synchronous pattern of EMG activity, has also been previously described in Parkinson's disease. We investigated the electrophysiological and pharmacological properties of both the RT and PT of 11 patients with Parkinson's disease and 10 patients with essential tremor in a double-blind, placebo-controlled study of L-Dopa/benserazide and propranolol. Tremor amplitude and frequency were assessed via bidirectional accelerometry, and the pattern of activation of the antagonist muscles of the forearm was determined with use of surface EMG. In the Parkinson's disease group studied, the frequency, EMG pattern of bursts, and response to L-Dopa were similar for the two tremors (median improvement of RT by 70% and PT by 61%). Despite some overlap between the Parkinson's disease and essential tremor groups in the electrophysiology of the tremor, there was no such dramatic pharmacological response in the latter group. These results suggest that the RT and PT of Parkinson's disease share a common pathophysiology and are distinct from essential tremor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 9316673     DOI: 10.1097/00002826-199406000-00007

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  8 in total

1.  Tremor reduction by subthalamic nucleus stimulation and medication in advanced Parkinson's disease.

Authors:  Christian Blahak; Johannes C Wöhrle; Hans-Holger Capelle; Hansjörg Bäzner; Eva Grips; Ralf Weigel; Michael G Hennerici; Joachim K Krauss
Journal:  J Neurol       Date:  2007-03-02       Impact factor: 4.849

Review 2.  Distinguishing essential tremor from Parkinson's disease: bedside tests and laboratory evaluations.

Authors:  Mary Ann Thenganatt; Elan D Louis
Journal:  Expert Rev Neurother       Date:  2012-06       Impact factor: 4.618

Review 3.  Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association.

Authors:  Mario Zappia; Alberto Albanese; Elisa Bruno; Carlo Colosimo; Graziella Filippini; Paolo Martinelli; Alessandra Nicoletti; Graziella Quattrocchi; Giovanni Abbruzzese; Alfredo Berardelli; Roberta Allegra; Maria Stella Aniello; Antonio E Elia; Davide Martino; Daniela Murgia; Marina Picillo; Giovanna Squintani
Journal:  J Neurol       Date:  2012-08-11       Impact factor: 4.849

4.  Volitional Suppression of Parkinsonian Resting Tremor.

Authors:  Rebekah L Blakemore; Michael R MacAskill; Daniel J Myall; Tim J Anderson
Journal:  Mov Disord Clin Pract       Date:  2019-07-01

Review 5.  Impact of Tremor on Patients With Early Stage Parkinson's Disease.

Authors:  Lauren E Heusinkveld; Mallory L Hacker; Maxim Turchan; Thomas L Davis; David Charles
Journal:  Front Neurol       Date:  2018-08-03       Impact factor: 4.003

6.  The nature of postural tremor in Parkinson disease.

Authors:  Michiel F Dirkx; Heidemarie Zach; Bastiaan R Bloem; Mark Hallett; Rick C Helmich
Journal:  Neurology       Date:  2018-02-23       Impact factor: 9.910

Review 7.  Beta-blocker therapy for tremor in Parkinson's disease.

Authors:  N J Crosby; K H O Deane; C E Clarke
Journal:  Cochrane Database Syst Rev       Date:  2003

8.  Combined accelerometer and genetic analysis to differentiate essential tremor from Parkinson's disease.

Authors:  Bhuvan Molparia; Brian N Schrader; Eli Cohen; Jennifer L Wagner; Sandeep R Gupta; Sherrie Gould; Nelson Hwynn; Emily G Spencer; Ali Torkamani
Journal:  PeerJ       Date:  2018-07-20       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.